Multiple, Sequential Light, Laser Sources No Benefit in Rosacea

This article originally appeared here.
Share this content:
Multiple, Sequential Light, Laser Sources No Benefit in Rosacea
Multiple, Sequential Light, Laser Sources No Benefit in Rosacea

MONDAY, July 18, 2016 (HealthDay News) -- Use of multiple, sequential light and laser sources to activate aminolevulinic acid (ALA) in photodynamic therapy (PDT) does not lead to statistically significant improvements in patient outcome for rosacea, according to a study published online July 4 in the Journal of Cosmetic Dermatology.

Daniel P. Friedmann, M.D., from Westlake Dermatology & Cosmetic Surgery in Austin, Texas, and colleagues examined ALA-PDT for rosacea using blue light sequentially with red light, pulsed-dye laser (PDL), and/or intense pulsed light (IPL) in a retrospective study involving 39 patients. Treatment groups were: blue light + PDL; blue light + IPL; blue light + PDL + IPL; and blue light + red light + PDL + IPL. A telephone questionnaire was used to obtain patient-reported outcome measures.

The researchers found that patient-reported rosacea and overall skin quality improvement were not significantly different between the groups. The only significant difference in post-procedure adverse events was decreased peeling following blue light + IPL compared with blue light + PDL (P = 0.041) and blue light + IPL + PDL (P = 0.005).

"The use of multiple, sequential light and laser sources with ALA-PDT for rosacea, while well tolerated, did not lead to statistically significant improvements in patient-reported efficacy," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »